The inhibitor has been approved for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen. OLYSIO works by blocking the viral protease enzyme that enables the hepatitis C virus to replicate in host cells.
More Articles on Supply Chain:
5 Ways Materials Management Information Systems Can Improve Surgery Center Supply Chain
Mazor Robotics’ Sells Renaissance Spine System to Lawnwood Regional Medical Center
Alphatec Spine Posts $14.5M Q3 Loss After PurGen Device Discontinuation
Register to Attend Webinar
Presenters:
Mark Miller, Naviant|Jason Bui, UiPath|Jessica Wilborne, BlueCross BlueShield of North Carolina|Colleen Bubnack, UiPath
Next Up in Supply Chain
-
BD has entered a partnership with the U.S. government to expand domestic manufacturing and supply chain capacity for essential medical…
-
Phoenix-based Valleywise Health has become the first hospital in Arizona to implement the LifeBubble Umbilical Line Securement System for premature…
-
Vizient has unveiled three solutions designed to help health systems address performance gaps across the supply chain lifecycle. The tools…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
